EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Editor's Choice – Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial

Maarit A Venermo, Alik Farber, Andres Schanzer, Matthew T Menard, Kenneth Rosenfield, Hasan Dosluoglu, Philip P Goodney, Ahmed M Abou-Zamzam, Raghu Motaganahalli, Gheorghe Doros, Mark A Creager

European Journal of Vascular and Endovascular Surgery · 2024

DOI: 10.1016/j.ejvs.2024.06.018 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2024. Verfasst von Maarit A Venermo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Helsinki University Central Hospital, Helsinki, Finland. Electronic address: Maarit.venermo@hus.fi. Hauptthemen laut MEDLINE: Amputation, Surgical, Endovascular Procedures. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: BEST-CLI, an international randomised trial, compared an initial strategy of bypass surgery with endovascular treatment in chronic limb threatening ischaemia (CLTI). In this substudy, overall amputation rates and risk of major amputation as an initial or subsequent outcome were evaluated. METHODS: A total of 1 830 patients were randomised to receive surgical or endovascular treatment in two parallel cohorts: patients with adequate single segment great saphenous vein (SSGSV) (n = 1 434) were assigned to cohort 1; and patients without adequate SSGSV (n = 396) were assigned to cohort 2. Differences in time to first event and number of amputations were evaluated. RESULTS: In cohort 1, there were 410 (45.6%) total amputation events in the surgical group vs. 490 (54.4%) in the endovascular group (p = .001) during a mean follow up of 2.7 years. Approximately one in three patients underwent minor amputation after index revascularisation: 31.5% of the surgical group vs. 34.9% in the endovascular group (p = .17). Subsequent major amputation was required significantly less often in the surgical group compared with the endovascular group (15.0% vs. 25.6%; p = .002). The first amputation was major in 5.6% of patients in the surgical group and 6.0% in the endovascular group (p = .72). Major amputation was required in 10.3% (74/718) of patients in the surgical group and 14.9% (107/716) in the endovascular group (p = .008). In cohort 2, there were 199 amputation events in 132 patients (33.3%) during a mean follow up of 1.6 years: 95 (47.7%) in the surgical group vs. 104 (52.3%) in the endovascular group (p = .49). Major amputation was required in 15.2% (30/197) of patients in the surgical group and 14.1% (28/199) in the endovascular group (p = .74). CONCLUSION: In patients with CLTI, surgical bypass with SSGSV was more effective than endovascular treatment in preventing major amputations, mainly due to a decrease in major amputations subsequent to minor amputations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amputation, SurgicalEndovascular ProceduresHumansFemaleMaleAgedMiddle AgedTreatment OutcomeTime FactorsIschemiaLimb SalvageSaphenous VeinPeripheral Arterial DiseaseChronic Limb-Threatening IschemiaRisk FactorsAged, 80 and overVascular Grafting

Stichwörter der Autor:innen

AmputationBypass surgeryChronic limb threatening ischaemiaEndovascularRevascularisation

Autor:innen und Institutionen

  • Department of Vascular Surgery, Helsinki University Central Hospital, Helsinki, Finland. Electronic address: Maarit.venermo@hus.fi.
  • Division of Vascular and Endovascular Surgery, Boston Medical Centre, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Division of Vascular Surgery, UMass Chan Medical School, Worcester, MA, USA.
  • Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Section of Vascular Medicine and Intervention, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Vascular Surgery, Jacobs School of Medicine and Biomedical Sciences, SUNY at Buffalo, Buffalo, NY, USA.

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute

Zitieren

APA

Venermo, M. A., Farber, A., Schanzer, A., Menard, M. T., Rosenfield, K., Dosluoglu, H., Goodney, P. P., Abou-Zamzam, A. M., Motaganahalli, R., Doros, G., & Creager, M. A. (2024). Editor's Choice – Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2024.06.018

Vancouver

Venermo MA, Farber A, Schanzer A, Menard MT, Rosenfield K, Dosluoglu H, et al. Editor's Choice – Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial. European Journal of Vascular and Endovascular Surgery. 2024. doi:10.1016/j.ejvs.2024.06.018

BibTeX
@article{Venermo2024,
  author = {Venermo, Maarit A and Farber, Alik and Schanzer, Andres and Menard, Matthew T and Rosenfield, Kenneth and Dosluoglu, Hasan and Goodney, Philip P and Abou-Zamzam, Ahmed M and Motaganahalli, Raghu and Doros, Gheorghe and Creager, Mark A},
  title = {Editor's Choice – Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2024},
  doi = {10.1016/j.ejvs.2024.06.018}
}
Kostenlos starten →